Tested Applications
| Positive WB detected in | NK-92 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
17762-1-AP targets GM-CSF in WB, IHC, IF, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse, rat, hamster |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag12142 Product name: Recombinant human CSF2 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-144 aa of BC108724 Sequence: MWLQSLLLLGTVACSISAPARSPSPSTQPWEHVNAIQEARRLLNLSRDTAAEMNETVEVISEMFDLQEPTCLQTRLELYKQGLRGSLTKLKGPLTMMASHYKQHCPPTPETSCATQIITFESFKENLKDFLLVIPFDCWEPVQE Predict reactive species |
| Full Name | colony stimulating factor 2 (granulocyte-macrophage) |
| Calculated Molecular Weight | 144 aa, 16 kDa |
| Observed Molecular Weight | 15kDa,18 kDa ,22 kDa |
| GenBank Accession Number | BC108724 |
| Gene Symbol | GM-CSF |
| Gene ID (NCBI) | 1437 |
| RRID | AB_2276718 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P04141 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
Granulocyte-macrophage colony-stimulating factor (GM-CSF), also known as colony-stimulating factor 2 (CSF2), is a monomeric glycoprotein secreted by macrophages, T cells, mast cells, natural killer cells, endothelial cells and fibroblasts. GM-CSF is a hematopoietic growth factor that stimulates the development of early erythroid megakaryocytic and eosinophilic progenitor cells (PMID 2990035). GM-CSF stimulates stem cells to produce granulocytes (neutrophils, eosinophils, and basophils) and monocytes (PMID 3021817, 2984574, 6390681).
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for GM-CSF antibody 17762-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The GM-CSF Polyclonal antibody (Cat# 17762-1-AP) has 43 citations. These appear in journals including Nature Nanotechnology, Journal of Experimental Medicine, Cancer Letters, Oncogene, Journal of Immunology, Gut Microbes, Journal of Neuroinflammation, International Immunopharmacology, Frontiers in Immunology, and Scientific Reports. Research fields span oncology (pancreatic, gastric, breast, bladder, colorectal, and melanoma cancers), immunology and immune checkpoint therapy, inflammation, fibrosis, macrophage polarization, preeclampsia, and neuroinflammation. Applications mainly include Western blot, IHC, and IF.
| Species | Application | Title |
|---|---|---|
J Hematol Oncol FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion | ||
Nat Nanotechnol A bispecific nanosystem activates endogenous natural killer cells in the bone marrow for haematologic malignancies therapy | ||
Adv Sci (Weinh) Modular Hydrogel Vaccine for Programmable and Coordinate Elicitation of Cancer Immunotherapy | ||
Cancer Lett HIF-1α mediates tumor-nerve interactions through the up-regulation of GM-CSF in pancreatic ductal adenocarcinoma. | ||
J Immunother Cancer Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trial |

